FDA Inspection 1090483 — Liveyon

Liveyon — FEI 3013957857

The FDA completed an inspection of Liveyon on May 23, 2019 in Yorba Linda, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
May 23, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Yorba Linda, CA (United States)

Citations

IDCFRDescription
241921 CFR 211.198(a)Complaint Handling Procedure